Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Nuwellis Inc (NASDAQ:NUWE) Stock Attempts To Recover: Time to Buy Now?

Nuwellis Inc (NASDAQ:NUWE), which was previously known as CHF Solutions Inc, was in focus among many investors yesterday and in fact, the company’s stock jumped by as much as 7%.

The gains made by the stock is expected to bring the stock into focus among many investors today but at the same time it is necessary to point out that there was no news about the company yesterday. Nuwellis is involved in providing access to its ultrafiltration therapies for patients who might be suffering from a case of fluid overload.

Back on June 22, the company had announced that it appointed a new Chief Financial Officer in the form of George Montague. The appointment went into effect on June 28, 2021. However, that is not all. The company also appointed Neil P.

Ayotte Esq to a range of roles. Ayotte was appointed as the Senior Vice President, Secretary, General Counsel and Chief Compliance Officer at Nuwellis. His appointment went into effect on June 7, 2021. The President and Chief Executive Officer of the company Nestor Jaramillo Jr stated that the two appointments are going to be vital for the company as it enters a new phase in which there are going to be major opportunities.  

Market Reaction:

On Monday, NUWE stock jumped 6.81% at $4.08 with more than 1.61 million shares, compared to its average volume of 189k shares. The stock has moved within a range of $3.8100 – 4.9000 after opening the trade at $3.8492. Over the past 52-week, the stock has been trading within a range of $3.4200 – 37.5000.